Harbor Investment Advisory’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.7K Buy
409
+185
+83% +$38.3K 0.01% 625
2026
Q1
$50.3K Sell
224
-59
-21% -$14.7K ﹤0.01% 622
2025
Q4
$68.2K Hold
283
0.01% 594
2025
Q3
$77.5K Hold
283
0.01% 553
2025
Q2
$73K Hold
283
0.01% 559
2025
Q1
$63.4K Sell
283
-40
-12% -$9.34K 0.01% 558
2024
Q4
$73.9K Hold
323
0.01% 522
2024
Q3
$78.9K Sell
323
-1
-0.3% -$223 0.01% 508
2024
Q2
$62K Buy
324
+1
+0.3% +$203 0.01% 542
2024
Q1
$64K Hold
323
0.01% 535
2023
Q4
$55.6K Hold
323
0.01% 550
2023
Q3
$47.8K Hold
323
0.01% 552
2023
Q2
$70.6K Hold
323
0.01% 604
2023
Q1
$70.7K Hold
323
0.01% 601
2022
Q4
$67.2K Hold
323
0.01% 601
2022
Q3
$71K Sell
323
-31
-9% -$7.06K 0.01% 566
2022
Q2
$74K Sell
354
-5
-1% -$1.06K 0.01% 578
2022
Q1
$87K Hold
359
0.01% 580
2021
Q4
$94K Buy
359
+10
+3% +$2.6K 0.01% 554
2021
Q3
$92K Sell
349
-20
-5% -$5.47K 0.01% 554
2021
Q2
$91K Sell
369
-15
-4% -$3.15K 0.01% 533
2021
Q1
$75K Buy
384
+25
+7% +$5.01K 0.01% 565
2020
Q4
$76K Hold
359
0.01% 514
2020
Q3
$62K Sell
359
-31
-8% -$5.72K 0.01% 452
2020
Q2
$75K Buy
390
+90
+30% +$14.7K 0.02% 389
2020
Q1
$44K Hold
300
0.01% 427
2019
Q4
$46K Buy
+300
New +$43.2K 0.01% 423

Other funds holding RMD

Harbor Investment Advisory's RMD Position: Q2 2026 in Review

Harbor Investment Advisory increased its ResMed (RMD) stake by 83% in Q2 2026, buying an estimated $38.3K and bringing the position to 409 shares worth $79.7K. The position accounts for 0.01% of the portfolio, ranked #625.

Harbor Investment Advisory first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $94K in Q4 2021. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Harbor Investment Advisory held 409 shares of ResMed worth $79.7K as of Q2 2026.
  • Harbor Investment Advisory bought 185 ResMed shares in Q2 2026, an estimated $38.3K.
  • ResMed made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #625 holding.
  • Harbor Investment Advisory first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's ResMed position peaked at $94K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.